Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e989-e997
DOI: 10.1210/clinem/dgad206 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 27.04.2023. Verfasst von Paul Fellinger und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Acromegaly, Human Growth Hormone, Insulin Resistance, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund.
Abstract (Originalsprache)
Context
Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I) excess, suggest an inverse relationship with intrahepatic lipid (IHL) content, less is known about the impact of the GH/IGF-I axis on IHL, lipid composition, and phosphor metabolites in individuals without disorders of GH secretion.
Objective
The aim was to investigate the relation between activity of the GH/IGF-I axis and IHL content and phosphor metabolism.
Methods
We performed a cross-sectional study in 59 otherwise metabolically healthy individuals (30 females), of which 16 met the criteria of NAFLD with IHL of ≥5.6%. The GH/IGF-I axis was evaluated in a fasting state and during an oral glucose tolerance test (OGTT). Insulin sensitivity was estimated by validated indices. IHL, lipid composition (unsaturation index), and phosphate metabolites were analyzed by using 1H/31P magnetic resonance spectroscopy.
Results
In the overall cohort (40.6 ± 15 years; body mass index: 24.5 ± 3 kg/m2; IGF-I: 68.0 ± 17% upper limit of normal), fasting GH (R = −0.31; P = .02), GH during oral glucose tolerance test (R = −0.51; P < .01), and IGF-I (R = −0.28; P = .03) inversely correlated with IHL. GH levels during OGTT were significantly lower in NAFLD than in controls (47.7 [22; 143] ng/mL/min vs 16.8 [7; 32] ng/mL/min; P = .003). GH/IGF-I axis activity correlated with lipid composition and with phosphor metabolites. In multiple regression analysis, the GH/IGF-I axis activity was a strong predictor for IHL and lipid composition independent from insulin sensitivity.
Conclusion
GH/IGF-I axis activity impacts hepatic lipid and phosphate metabolism in individuals without disorders in GH secretion. Lower GH axis activity is associated with higher IHL and an unfavorable lipid composition, probably mediated by changes in hepatic energy metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
- Centre of Excellence-High Field MR, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Paul Fellinger, Hannes Beiglböck, Georg Semmler, Greisa Vila, Michael Krebs, Peter Wolf
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund
Zitieren
APA
Fellinger, P., Beiglböck, H., Semmler, G., Pfleger, L., Smajis, S., Baumgartner, C., Gajdosik, M., Marculescu, R., Vila, G., Winhofer, Y., Scherer, T., Trauner, M., Kautzky-Willer, A., Krssak, M., Krebs, M., & Wolf, P. (2023). Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism. The Journal of Clinical Endocrinology & Metabolism, 108(10), e989-e997. https://doi.org/10.1210/clinem/dgad206
Vancouver
Fellinger P, Beiglböck H, Semmler G, Pfleger L, Smajis S, Baumgartner C, et al. Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e989-e997. doi:10.1210/clinem/dgad206
BibTeX
@article{Fellinger2023,
author = {Fellinger, Paul and Beiglböck, Hannes and Semmler, Georg and Pfleger, Lorenz and Smajis, Sabina and Baumgartner, Clemens and Gajdosik, Martin and Marculescu, Rodrig and Vila, Greisa and Winhofer, Yvonne and Scherer, Thomas and Trauner, Michael and Kautzky-Willer, Alexandra and Krssak, Martin and Krebs, Michael and Wolf, Peter},
title = {Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {10},
pages = {e989--e997},
doi = {10.1210/clinem/dgad206}
}
EUVIMED